Healx

Healx Combines AI with Expert Pharmacology to Discover New Therapies for Rare Diseases and Accelerate Them into Clinical Trials within 2 Years. To Achieve This Goal, Healx Has Developed the Most Comprehensive AI-based Rare Disease Drug Discovery Platform: HealNet. HealNet Disrupts the Traditional Drug Discovery Process, Reducing the Cost, Time, and Risk of Bringing New Therapies to Market. Healx’s Plan Is to Deliver 100 Treatments for Rare Diseases in Development by 2025.